Public Policy Staffing Study Offers Benchmark Opportunity for Bio-Pharma and Medical Device Companies
Jan 13, 2012, 04:12 ET
CHAPEL HILL, N.C., Jan. 13, 2012 /PRNewswire/ -- Bio-Pharmaceutical and medical device leaders are re-evaluating their staffing and investment levels in light of increasing regulatory and market pressures in the U.S., according to analysts at research and consulting firm Best Practices, LLC.
To identify which resourcing strategies will best reduce risk and enhance growth in the quickly changing healthcare industry, Best Practices, LLC, a world-leader in biopharmaceutical benchmarking and best practice research, has launched a new study: "Public Affairs and Public Policy Staffing in the U.S. Marketplace for Biopharmaceutical and Medical Device Companies."
This landmark study comprises wide-ranging staffing investment insights from bio-pharma and medical device executives across areas such as Structure and Reporting Relationships, Staffing and Investment and Consolidated Staffing and Investment Efficiency Ratios for the following functions:
- Government Affairs (State and Federal Government Relations and Public Policy)
- Corporate Communications – External
- Corporate Communication – Internal
- Product Communications
- Corporate Social Responsibility
- Alliance Management
This critical research study represents the latest contribution of Best Practices, LLC to the life science industry's staffing and investment knowledge. While previous studies have captured key metrics to identify optimal resource levels for maximum competitiveness, regulatory and other changes have continued to erode the effectiveness of the industry's proven business model - a fact pressing executives to reconsider efficient levels of human and capital investment.
This latest study therefore offers an open benchmark opportunity for public affairs/public policy executives throughout the bio-pharma and medical device sectors.
For assistance or questions related to this study, contact research team leader Cameron Tew at [email protected] or (919) 767-9246. Responses are requested by Feb. 21, 2012.
There is no cost to participate, and all benchmark participants will receive the complete, blinded research results and analysis for free. This study will generate comparative metrics and executive insights that participants can use in the future to help assess what staffing and investment levels are right for different sizes of company.
All responses are blinded and aggregated to protect confidentiality. To view or participate in the online survey, follow this link: http://app.sgizmo.com/preview_survey.php?id=91334&k=I1283c7fxPu28NtobvbYNIfk4eEhy0&u=pwalve%40best-in-class%2ecom
BEST PRACTICES, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies.
The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.
Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.
SOURCE Best Practices, LLC
Share this article